Pathogen prevalence may determine maintenance of antigen-specific T-cell responses in HIV-infected individuals

AIDS

Volumn 26, Issue 6, 2012, Pages 695-700

  Schuetz, Alexandra ^a,b,c   Dirks, Jan ^a   Sester, Urban ^a   Haule, Antelmo ^b   Elias, Nyanda ^b   Geldmacher, Christof ^b,c   Sanga, Erica ^b   Maboko, Leonard ^b   Reither, Klaus ^c   Hoelscher, Michael ^c   Meyerhans, Andreas ^a,d   Sester, Martina ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b NIMR Mbeya Medical Research Project   (Tanzania)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

antiretroviral therapy; HIV infection; Mycobacterium tuberculosis; purified protein derivative; T cell; T cell repertoire; T cell specificity; tuberculosis

Indexed keywords

STAPHYLOCOCCUS ENTEROTOXIN B; TUBERCULIN;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TUBERCULOSIS;

ADULT; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES;

EID: 84859103667     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283519a89     Document Type: Article

References (17)

1. WHO. Global tuberculosis control 2010. In. Geneva: World Health Organisation; 2010:1-218. http://whqlibdoc.who.int/ publications/2010/ 9789241564069-eng.pdf.
2. Sester M, Giehl C, McNerney R, Kampmann B, Walzl G, Cuchi P, et al. Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection. Eur Respir J 2010; 36:1242-1247.
3. Geldmacher C, Schuetz A, Ngwenyama N, Casazza JP, Sanga E, Saathoff E, et al. Early depletion ofMycobacterium tuberculosis- specific T helper 1 cell responses after HIV-1 infection. J Infect Dis 2008; 198:1590-1598.
4. Guihot A, Bourgarit A, Carcelain G, Autran B. Immune reconstitution after adecade of combined antiretroviral therapies for human immunodeficiency virus. Trends Immunol 2011; 32:131-137.
5. Sester U, Wilkens H, van Bentum K, Singh M, Sybrecht GW, Schäfers HJ, Sester M. Impaired detection ofMycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs. Eur Respir J 2009; 34:702-710.
6. Sester U, Junker H, Hodapp T, Schütz A, Thiele B, Meyerhans A, et al. Improved efficiency indetecting cellular immunity towards M. tuberculosis in patients receiving immunosuppressive drug therapy. Nephrol Dial Transplant 2006; 21:3258-3268. (Pubitemid 44567103)
7. Gandhi MK, Wills MR, Okecha G, Day EK, Hicks R, Marcus RE, et al. Late diversification inthe clonal composition of human cytomegalovirus-specific CD8R+ T cells following allogeneic hemopoietic stem cell transplantation. Blood 2003; 102:3427-3438. (Pubitemid 37314786)
8. WHO. Tuberculosis country profiles. http://www.who.int/tb/ data. [Accessed on 15 November 2011].
9. Sester M, Sester U, Clauer P, Heine GH, Mack U, Moll T, et al. Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney Int 2004; 65:1826-1834. (Pubitemid 38591032)
10. Sester U, Fousse M, Dirks J, Mack U, Prasse A, Singh M, et al. Whole-blood flow-cytometric analysis ofantigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from nonactive States. PLoS One 2011; 6:e17813.
11. Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D, et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009; 33:956-973.
12. Brenchley JM, Hill BJ, Ambrozak DR, Price DA, Guenaga FJ, Casazza JP, et al. T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. J Virol 2004; 78:1160-1168. (Pubitemid 38095826)
13. Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, Hogan C, et al. Primary HIV-1 infection isassociated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004; 200:761-770. (Pubitemid 39299462)
14. Puissant-Lubrano B, Combadiere B, Duffy D, Wincker N, Frachette MJ, Ait-Mohand H, et al. Influence ofantigen exposure on the loss of long-term memory to childhood vaccines in HIV-infected patients. Vaccine 2009; 27:3576-3583.
15. Sester U, Sester M, Köhler H, Pees HW, Gärtner BC, Wain- Hobson S, et al. Maintenance ofHIV-specific central and effector memory CD4 and CD8 T cells requires antigen persistence. AIDS Res Hum Retroviruses 2007; 23:549-553. (Pubitemid 46700888)
16. Dheda K, van Zyl Smit R, Badri M, Pai M. T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med 2009; 15:188-200.
17. Elzi L, Schlegel M, Weber R, Hirschel B, Cavassini M, Schmid P, et al. Reducing tuberculosis incidence bytuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis 2007; 44:94-102. (Pubitemid 44968992)